Market revenue in 2023 | USD 2,843.6 million |
Market revenue in 2030 | USD 5,195.9 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Total parenteral nutrition |
Fastest growing segment | Total Parenteral Nutrition |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Total Parenteral Nutrition, Peripheral Parenteral Nutrition |
Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition was the largest segment with a revenue share of 65.9% in 2023. Horizon Databook has segmented the Asia Pacific intravenous solutions market based on total parenteral nutrition, peripheral parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
China and Japan majorly drive the economy of Asia Pacific region. China dominated the overall market in terms of revenue share owing to high R&D expenditure by public & private entities in the research sector, technological advancements, and the collaborations between various stakeholders, including the medical fraternity & universities.
The growing prevalence of chronic diseases due to unhealthy eating habits and rising demand for cost effective care treatment are some of the factors expected to drive market growth. Moreover, increasing population, poverty, and low awareness about nutrition are leading to malnutrition, which is one of the key factors boosting market demand.
Significant unmet healthcare needs, high out-of-pocket healthcare spending, and rapidly growing purchasing power to access various technologically advanced healthcare services are expected to boost the market over the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific intravenous solutions market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific intravenous solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account